Baclofen extended release - Intec Pharma

Drug Profile

Baclofen extended release - Intec Pharma

Alternative Names: Accordian pill baclofen; AP-Baclofen; Baclofen GR

Latest Information Update: 16 Jul 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Intec Pharma
  • Class Aminobutyric acids; Antispastics; Muscle relaxants; Small molecules
  • Mechanism of Action GABA B receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Muscle spasticity

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for phase-I development in Muscle-spasticity in Israel (PO, Controlled release)
  • 22 Oct 2015 Intec Pharma has patent protection for Accordion Pill platform in Europe
  • 03 Aug 2009 Phase-I clinical trials in Spasticity in Israel (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top